Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Auerswald

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Hamostaseologie|May 5, 2007
[Long-term prophylaxis in congenital haemophilia with inhibitors - experiences with rFVIIa]G Auerswald
Thrombosis Research|April 1, 2006
Prophylaxis in rare coagulation disorders -- factor X deficiencyG Auerswald
MMW Fortschritte Der Medizin|September 24, 2009
[Diagnosis of coagulation disorders: first steps to be done]G Auerswald
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 17, 2008
Haemate P/Humate-P for the treatment of von Willebrand disease: considerations for use and clinical experienceG Auerswald, W Kreuz
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 29, 2011
Early prophylaxis/FVIII tolerization regimen that avoids immunological danger signals is still effective in minimizing FVIII inhibitor developments in previously untreated patients--long-term follow-up and continuing experienceG Auerswald, C Bidlingmaier, K Kurnik
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 8, 2009
Haemophilia care in children--benefits of early prophylaxis for inhibitor preventionM E Mancuso, L Graca, G Auerswald, et al.
Fortschritte Der Medizin|December 4, 1975
[Modification of infectious-allergic processes by oral administration of antigens]H Stickl, G Auerswald, U Boden, et al.
Thrombosis and Haemostasis|November 1, 1994
Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitorsS Ehrenforth, W Kreuz, M Funk, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 27, 2018
Muscle function deterioration in patients with haemophilia: Prospective experience from Costa RicaA Seuser, M Navarrete-Duran, G Auerswald, et al.
Hamostaseologie|November 3, 2010
[Inhibitor development after early high exposure and cerebral haemorrhage. Costs and factor demand for a successful immunotolerance induction therapy]K Haubold, C Moorthi, A Bade, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Hamostaseologie|May 5, 2007
[Long-term prophylaxis in congenital haemophilia with inhibitors - experiences with rFVIIa]G Auerswald
Thrombosis Research|April 1, 2006
Prophylaxis in rare coagulation disorders -- factor X deficiencyG Auerswald
MMW Fortschritte Der Medizin|September 24, 2009
[Diagnosis of coagulation disorders: first steps to be done]G Auerswald
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 17, 2008
Haemate P/Humate-P for the treatment of von Willebrand disease: considerations for use and clinical experienceG Auerswald, W Kreuz
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 29, 2011
Early prophylaxis/FVIII tolerization regimen that avoids immunological danger signals is still effective in minimizing FVIII inhibitor developments in previously untreated patients--long-term follow-up and continuing experienceG Auerswald, C Bidlingmaier, K Kurnik
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 8, 2009
Haemophilia care in children--benefits of early prophylaxis for inhibitor preventionM E Mancuso, L Graca, G Auerswald, et al.
Fortschritte Der Medizin|December 4, 1975
[Modification of infectious-allergic processes by oral administration of antigens]H Stickl, G Auerswald, U Boden, et al.
Thrombosis and Haemostasis|November 1, 1994
Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitorsS Ehrenforth, W Kreuz, M Funk, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 27, 2018
Muscle function deterioration in patients with haemophilia: Prospective experience from Costa RicaA Seuser, M Navarrete-Duran, G Auerswald, et al.
Hamostaseologie|November 3, 2010
[Inhibitor development after early high exposure and cerebral haemorrhage. Costs and factor demand for a successful immunotolerance induction therapy]K Haubold, C Moorthi, A Bade, et al.
Pageof 5